BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3415232)

  • 1. Seroepidemiology of cholera in Gulf coastal Texas.
    Hunt MD; Woodward WE; Keswick BH; Dupont HL
    Appl Environ Microbiol; 1988 Jul; 54(7):1673-7. PubMed ID: 3415232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
    Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
    J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
    Levine MM; Black RE; Clements ML; Cisneros L; Saah A; Nalin DR; Gill DM; Craig JP; Young CR; Ristaino P
    J Infect Dis; 1982 Mar; 145(3):296-9. PubMed ID: 7061878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on V. cholerae anti-antibodies (agglutinating and vibriocidal) in patients affected by cholera-like gastroenteritis. Studies performed during the cholera epidemic occurred in Apulia in August-September 1973].
    Barbuti S; Iandolo E; Rizzo G; Leogrande G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):449-59. PubMed ID: 1084731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
    Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
    Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera--a possible endemic focus in the United States.
    Blake PA; Allegra DT; Snyder JD; Barrett TJ; McFarland L; Caraway CT; Feeley JC; Craig JP; Lee JV; Puhr ND; Feldman RA
    N Engl J Med; 1980 Feb; 302(6):305-9. PubMed ID: 7350497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of cholera associated with crab brought from an area with epidemic disease.
    Finelli L; Swerdlow D; Mertz K; Ragazzoni H; Spitalny K
    J Infect Dis; 1992 Dec; 166(6):1433-5. PubMed ID: 1431260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.
    Qadri F; Mohi G; Hossain J; Azim T; Khan AM; Salam MA; Sack RB; Albert MJ; Svennerholm AM
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):685-8. PubMed ID: 8574829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.
    Weil AA; Chowdhury F; Khan AI; Leung DT; Uddin T; Begum YA; Saha NC; Charles RC; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
    Am J Trop Med Hyg; 2012 Nov; 87(5):921-6. PubMed ID: 22964723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.
    Young CR; Levine MM; Craig JP; Robins-Browne R
    Infect Immun; 1980 Feb; 27(2):492-6. PubMed ID: 7189746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
    Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
    Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroepidemiology of cholera in Mexico].
    González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
    Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.
    Haney DJ; Lock MD; Simon JK; Harris J; Gurwith M
    Clin Vaccine Immunol; 2017 May; 24(8):. PubMed ID: 28566334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.